Uncategorized

Vertex inks $10B Crinetics buy, entering ‘white space blockbuster opportunity’

Published

on

Vertex Pharmaceuticals’ acquisition of Crinetics Pharmaceuticals is the largest pickup in the company’s history, according to analysts at BMO Capital Markets.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version